Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0001610717-24-000259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-22 | TXG | McAnear Justin J. | CFO | S - Sale | $24.30 | -2,936 | 146.2K | -2% | -$71.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-22 | S | D | 2,936 | $24.30 | 146,203 | D | — | — | (F2) Includes 587 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 14, 2024. |